These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7225388)

  • 21. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of rates of H+, Na+ and K+ transport across phospholipid vesicular membrane by the combined action of carbonyl cyanide m-chlorophenylhydrazone and valinomycin: temperature-jump studies.
    Prabhananda BS; Kombrabail MH
    Biochim Biophys Acta; 1995 May; 1235(2):323-35. PubMed ID: 7756342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomotropic behavior of adrenergic antagonists in interactions with human neutrophils.
    Styrt B; Klempner MS
    Biochem Pharmacol; 1988 Feb; 37(3):435-41. PubMed ID: 2892495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain.
    Rinne JO; Rinne JK; Laakso K; Paljärvi L; Rinne UK
    J Neurol Neurosurg Psychiatry; 1984 Jun; 47(6):651-2. PubMed ID: 6736999
    [No Abstract]   [Full Text] [Related]  

  • 26. [Solubilization by various detergents, of the muscarinic cholinoreceptor and its complex with quinuclidinyl benzilate].
    Rinken AA; Langel IuL; Iarv IaL
    Biokhimiia; 1987 Feb; 52(2):303-10. PubMed ID: 3567252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of high-affinity beta2-adrenergic receptor binding of (-)-[3H]-dihydroalprenolol to human polymorphonuclear cell particulates.
    Galant SP; Underwood S; Duriseti L; Insel PA
    J Lab Clin Med; 1978 Oct; 92(4):613-8. PubMed ID: 213511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the muscarinic receptor binding activity of some tertiary amines and their quaternary ammonium analogues.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1984 Jan; 25(1):46-50. PubMed ID: 6708935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered [3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate.
    Ehlert FJ; Kokka N; Fairhurst AS
    Mol Pharmacol; 1980 Jan; 17(1):24-30. PubMed ID: 7383017
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; Rogers WA; Gaginella TS
    Gastroenterology; 1979 Dec; 77(6):1225-34. PubMed ID: 499710
    [No Abstract]   [Full Text] [Related]  

  • 33. Muscarinic cholinergic binding in rat brain.
    Yamamura HI; Snyder SH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1725-9. PubMed ID: 4151898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine transport by membrane vesicles isolated from rat brain.
    Aragón MC; Giménez C; Mayor F; Marvizón JG; Valdivieso F
    Biochim Biophys Acta; 1981 Sep; 646(3):465-70. PubMed ID: 7284373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP-dependent acidification of intact and disrupted lysosomes. Evidence for an ATP-driven proton pump.
    Schneider DL
    J Biol Chem; 1981 Apr; 256(8):3858-64. PubMed ID: 7217060
    [No Abstract]   [Full Text] [Related]  

  • 37. Differentiation between ligand trapping into intact cells and binding on muscarinic receptors.
    Gossuin A; Maloteaux JM; Trouet A; Laduron P
    Biochim Biophys Acta; 1984 May; 804(1):100-6. PubMed ID: 6722181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of the interaction of dihydroalprenolol with beta-adrenergic receptors in rat cerebral cortex.
    Schliebs R; Bigl V
    Gen Physiol Biophys; 1984 Feb; 3(1):31-46. PubMed ID: 6086449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.